Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Medsol RX vs Push Health

Medsol RX
Graded #306

Higher grade

vs+4.799999999999997
Push Health
Graded #419

Lower grade

The verdict

Medsol RX takes it — 61/100 to 56.2/100.

Medsol RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Medsol RX is a GLP-1 weight-loss telehealth program offering compounded semaglutide (from $209/mo) and tirzepatide, prescribed by board-certified clinicians via OpenLoop and shipped nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMedsol RX +10
45
35
Dose & formulationPush Health +1
64
65
Clinical oversightMedsol RX +8
79
71
Labs & monitoringMedsol RX +1
53
52
FulfillmentMedsol RX +16
83
67
Contract termsPush Health +14
41
55
Medsol RX · left barPush Health · right bar

The numbers

MetricMedsol RXPush Health
WeighScore61/10056.2/100
GradeCC
Scorecard rank#306#419
Semaglutide$209/mo (compounded)$950/mo (brand-name)
Tirzepatide$250/mo (compounded)Not disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Medsol RX

Graded #306 · C

Strengths

  • Compounded semaglutide from $209/mo (12-mo plan) and tirzepatide from ~$250/mo; HSA/FSA eligible with Klarna financing
  • Every plan bundles the medication, a dedicated care coach, custom treatment plan, medical oversight, and free shipping
  • Board-certified clinicians via OpenLoop; same-day approvals; ships nationwide
  • Month-to-month option ($199 first month) with no long-term commitment, plus microdosing and wellness add-ons

Where it loses points

  • Doesn't name its compounding pharmacy (generic 'certified U.S. pharmacies')
  • No legal entity name published on the site
  • Tirzepatide pricing is given as a range ($250-$1,400/mo), not a fixed rate
  • Compounded GLP-1s are not FDA-approved (the site discloses this)
Push Health

Graded #419 · C

Strengths

  • Brand-name-only GLP-1 distribution (Ozempic, Zepbound, Mounjaro)
  • 55,000+ pharmacy network per competitor sources
  • LegitScript certified per competitor sources
  • Listed in both competitor directories

Where it loses points

  • Brand-name-only — no compounded option
  • Stub entry — exact pricing, insurance coordination, and clinician workflow need YMYL verification
  • Confidence LOW until verified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard